Surveyor Capital's book
20 companies · priced for members| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Kailera Therapeutics (NAS: KLRA) | — | ▮ | ▮ | ▮ | ▮ |
| Enveda | — | ▮ | ▮ | ▮ | ▮ |
| 35Pharma | — | ▮ | ▮ | ▮ | ▮ |
+ 17 more companies · all 20, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | |||||
Surveyor Capital portfolio at a glance
20 portfolio companies are on record for Surveyor Capital, including Kailera Therapeutics (NAS: KLRA), Enveda and 35Pharma. The book leans Drug Discovery (4) and Discovery Tools (Healthcare) (2).
20 of the 20 carry a recorded valuation.
Free account
See more of the book
- ·The top 10 names in the book — of 20 recorded positions
- ·Watchlist + alerts for Surveyor Capital's activity